<DOC>
	<DOC>NCT02133807</DOC>
	<brief_summary>To evaluate whether specific lipoprotein(a) apheresis on the top of optimal medical therapy could affect atherosclerotic disease burden in coronary and carotid arteries of coronary heart disease patients with elevated Lp(a) levels.</brief_summary>
	<brief_title>Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis</brief_title>
	<detailed_description>Following the hypothesis that if Lp(a) excess has a pathogenic role in atherogenesis, then specific elimination of circulating Lp(a) should affect plaque growth and stability, we evaluated the efficacy of Lp(a) apheresis on changes in coronary plaque volume and composition and carotid intima-media thickness in patients with CHD on the background of optimal medical treatment.</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Stable coronary heart disease (CHD) requiring a clinically indicated coronary angiography. Lp(a) ≥50 mg/dL LDLC &lt;2.6 mmol/L (100 mg/dL) Signed written informed consent form to participate in the study history of acute coronary syndrome or surgical intervention within prior 3 months to inclusion chronic infectious and inflammatory diseases familial hypercholesterolemia TG ≥4.5 mmol/L (400 mg/dL) Active liver disease (ALT or AST &gt;3 upper limit of normal (ULN), or total bilirubin &gt;1.5 ULN); CK ≥3 ULN; Thyroid dysfunction; Renal dysfunction (creatinine clearance (CockcroftGault Equation) ≤30 ml/min); Uncontrolled diabetes (HbA1c ≥7.0%); Coagulopathies; Lipidlowering drugs, except statins for the last month Known statin or immunoadsorption intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Lipoprotein(a);</keyword>
	<keyword>Lp(a) immunoadsorption;</keyword>
	<keyword>Apheresis;</keyword>
	<keyword>Coronary atherosclerosis;</keyword>
	<keyword>Carotid Atherosclerosis;</keyword>
	<keyword>Intima-media thickness;</keyword>
	<keyword>Regression;</keyword>
	<keyword>Quantitative Coronary Angiography;</keyword>
	<keyword>Intravascular Ultrasound;</keyword>
	<keyword>Virtual Histology;</keyword>
	<keyword>Plaque;</keyword>
	<keyword>Atorvastatin;</keyword>
</DOC>